Skip to content
Home - Products - Respiratory    

Rhinocort (budesonide)

Rhinocort (budesonide) is an anti-inflammatory glucocorticosteroid for the once-daily treatment of non-infectious rhinitis, and for treatment and prevention of nasal polyposis. Non-infectious rhinitis includes seasonal allergic rhinitis (hay fever), perennial allergic rhinitis (e.g. house dust mite allergy), and perennial non-allergic rhinitis.

The following nasal formulations of Rhinocort are available: RhinocortAqua (a water-based suspension in a pump spray), RhinocortTurbuhaler (nasal inhalation powder), and Rhinocort pMDI (pressurised metered dose inhaler).

Not all formulations of Rhinocort are available in every country.

Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

> Healthcare professionals
> Patients and familiesopens in a new window

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.



AstraZeneca websites
Search
Quick links
Information for